Logos Global Management LP Takes Stake in aTyr Pharma

TL;DR

**Logos Global Management LP just bought into aTyr Pharma, signaling potential upside.**

AI Summary

Logos Global Management LP, a California-based investment firm, has reported a significant stake in aTyr Pharma, Inc. (NASDAQ: ATYR), a biological products company. As of December 19, 2023, Logos Global Management LP filed an SC 13G, indicating they hold a substantial position in aTyr Pharma's common stock. This matters to investors because a large institutional investor taking a position can signal confidence in the company's future prospects, potentially influencing other investors and the stock price.

Why It Matters

A new institutional investor, Logos Global Management LP, has disclosed a position in aTyr Pharma, which could be seen as a vote of confidence and potentially attract more investor interest.

Risk Assessment

Risk Level: low — This filing indicates a new institutional investor, which is generally a positive signal and does not inherently increase risk.

Analyst Insight

A smart investor would research Logos Global Management LP's investment thesis and track aTyr Pharma's stock performance and news for any follow-up announcements, as institutional interest can often precede positive price movements.

Key Players & Entities

• Logos Global Management LP (company) — the reporting person and institutional investor
• aTyr Pharma, Inc. (company) — the subject company whose stock was acquired
• December 19, 2023 (date) — the date of the event requiring the filing
• 002120202 (number) — CUSIP number for aTyr Pharma's common stock
• $0.001 (dollar_amount) — par value of aTyr Pharma's common stock

FAQ

Key Financial Figures

• $0.001 — , Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti

Filing Documents

• atyr13g.htm (SC 13G) — 58KB
• 0000935836-24-000001.txt ( ) — 60KB

Ownership

Item 4. Ownership. See Items 5-9 and 11 of the cover page for each Filer. The percentages reported in this Schedule 13G are based on 58,560,061 shares of Common Stock outstanding as of November 3, 2023, as disclosed in the Form 10-Q filed by the Issuer on November 9, 2023.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. The funds managed by Logos Global, including Global Fund, hold the Stock for the benefit of their investors and have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable.

Certification

Item 10. Certification. Certification of Logos Global, Logos Global GP and Dr. William: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Certification of Global Fund and Logos GP: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. 8 CUSIP No. 002120202 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated:December 29, 2023 /s/ Arsani William Arsani William Logos Global Management LP By: /s/ Arsani William Name: Arsani William Title: Managing Partner Logos Global Master Fund LP By Logos Global Management LP, its investment manager and attorney-in-fact By: /s/ Arsani William Name: Arsani William Title: Managing Partner Logos Global Management GP LLC By: /s/ Arsani William Name: Arsani WIlliam Title: Managing Member Logos GP LLC By: /s/ Arsani William Name: Arsani William Title: Managing Member 9 CUSIP No. 002120202 EXHIBIT A AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G The undersigned agree to

View Full Filing

View this SC 13G filing on SEC EDGAR